Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to -$630409.0.

  • Cumberland Pharmaceuticals' Change in Inventory fell 46876.81% to -$630409.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year decrease of 49998.81%. This contributed to the annual value of -$2.4 million for FY2024, which is 1050658.95% down from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Change in Inventory stood at -$630409.0, which was down 46876.81% from -$850797.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Change in Inventory ranged from a high of $1.6 million in Q3 2022 and a low of -$2.3 million during Q1 2022
  • Moreover, its 5-year median value for Change in Inventory was -$630409.0 (2025), whereas its average is -$555862.5.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 75608.95% in 2022, then plummeted by 107311.23% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Change in Inventory (Quarter) stood at -$2.3 million in 2021, then surged by 118.92% to $427803.0 in 2022, then grew by 3.2% to $441498.0 in 2023, then plummeted by 402.63% to -$1.3 million in 2024, then skyrocketed by 52.82% to -$630409.0 in 2025.
  • Its Change in Inventory was -$630409.0 in Q3 2025, compared to -$850797.0 in Q2 2025 and -$967399.0 in Q1 2025.